The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
Key Details
- 1Mirai risk model analyzed 134,217 screening mammograms, including 524 interval cancers.
- 2Top 20% risk group by Mirai captured 42.4% of interval cancers, corresponding to 1.7 additional detections per 1,000 exams.
- 3AUC values for interval cancer prediction ranged from 0.67 to 0.72 across time, age, and breast density subgroups.
- 4No significant performance variation across different age groups or breast densities was observed.
- 5Mirai has been validated on nearly 2 million mammograms across 21 countries.
- 6Editorial comments highlight progress but note limitations since interval cancer detection did not surpass 50%.
Why It Matters
Interval cancers are a challenge in breast screening, often missed during routine exams and harder to detect. AI-driven risk models like Mirai offer a promising path to personalized screening strategies, potentially catching cancers earlier and improving patient outcomes.
Source
AuntMinnie
Related News
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.
•AuntMinnie
AI-Driven Whole-Body MRI Biomarkers Aid Myeloma Risk Stratification
AI-powered MRI analysis offers automated risk stratification via body composition in multiple myeloma patients.
•Radiology Business
AI Targets Radiology Residents’ Training Gaps for Personalized Learning
Artificial intelligence can identify gaps in radiology residents' clinical exposure, supporting tailored educational interventions.